Affordable Access

Errata

Publisher
American Diabetes Association
Publication Date
Volume
31
Issue
8
Identifiers
DOI: 10.2337/dc08-er08b
Keywords
  • Errata
Disciplines
  • Medicine

Abstract

Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams-Herman DE, for the Sitagliptin 036 Study Group: Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes. Diabetes Care 30:1979–1987, 2007 In Table 2 of the article above, an asterisk was missing denoting a significant difference between the 1,000 mg metformin b.i.d. group and placebo. The corrected table appears on the following page. The online version reflects these changes. Table 2 Efficacy end points following a meal tolerance test Parameter Placebo Sitagliptin 100 mg q.d. Metformin 500 mg b.i.d. Metformin 1,000 mg b.i.d. Sitagliptin 50 mg + metformin 500 mg b.i.d. Sitagliptin 50 mg + metformin 1,000 mg b.i.d. 2-h PPG (mg/dl)     n 129 136 141 138 147 152     Baseline 276.8 ± 66.7 285.4 ± 82.8 292.7 ± 74.6 283.4 ± 81.8 291.8 ± 84.6 286.9 ± 76.2     Week 24 281.3 ± 88.2 233.8 ± 89.5 236.3 ± 70.8 207.0 ± 69.4 196.3 ± 72.5 170.3 ± 58.6     Change from baseline 0.3 (−10.4 to 11.0) −51.9 (−62.3 to −41.5) −53.4 (−63.6 to −43.2) −78.0 (−88.3 to −67.6) −92.5 (−102.6 to −82.5) −116.6 (−126.4 to −106.7)

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Errata

on Nutrition Research and Practic... Jan 01, 2009

Errata

Jan 01, 1950

Errata.

on Plant cell reports May 1989

Errata.

on Bulletin of the Medical Librar... January 1999
More articles like this..